CILBIQTY
LIVE

Serial Number

79293256

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jul 13, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CILBIQTY Trademark

Serial Number: 79293256 • Registration: 6242305

CILBIQTY is a trademark filed by NOVARTIS AG on July 13, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

July 13, 2020

Registration Date

January 12, 2021

Published for Opposition

October 27, 2020

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 12, 2026 REM3
NOTIFICATION PROCESSED BY IB
Mar 13, 2021 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Feb 20, 2021 FICS
FINAL DISPOSITION PROCESSED
Feb 19, 2021 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Feb 11, 2021 GPAR
REGISTERED-PRINCIPAL REGISTER
Jan 12, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 27, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 27, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 7, 2020 NONP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 2, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 2, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 2, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 2, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 2, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 2, 2020 COAR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 21, 2020 CNSA
ASSIGNED TO EXAMINER
Sep 18, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 18, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 14, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 11, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 10, 2020 REPR